Incident Chlamydia trachomatis infections among inner-city adolescent females

JAMA

Volumn 280, Issue 6, 1998, Pages 521-526

  Burstein, Gale R ^a   Gaydos, Charlotte A ^a   Diener West, Marie ^a   Rene Howell, M ^a   Zenilman, Jonathan M ^a   Quinn, Thomas C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONDOM; FEMALE; FEMALE INFERTILITY; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASS SCREENING; PELVIC INFLAMMATORY DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

EID: 0032511362     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.6.521     Document Type: Article

References (56)

1. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydiatrachomatis infections. MMWR Morb Mortal Wkly Rep. 1993;42(RR-12):6-7.
2. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362-1366.
3. Brunham RC, Maclean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis. 1985;152:1275-1282.
4. World Organization Task Force on the Prevention and Management of Infertility. Tubal infertility. Sex Transm Dis. 1995;22:71-76.
5. Sellers JW, Mahony JB, Chernesky MA, Rath DJ. Tubal factor infertility. Fertil Steril. 1988;49:451-457.
6. Kelver ME, Nagamani M. Chlamydial serology in women with tubal infertility. Int J Fertil Womens Med. 1989;34:42-45.
7. Centers for Disease Control and Prevention. Chlamydiatrachomatis genital infections - United States, 1995. MMWR Morb Mortal Wkly Rep. 1997;46:193-198.
8. Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections-United States, 1995. JAMA. 1997;277:952-953.
9. Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydia infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis. 1998;177:417-424.
10. Schachter J, Shafer MA, Young M, Ott M. Routine pelvic examinations in asymptomatic young women. N Engl J Med. 1995;335:1847-1848.
11. Institute of Medicine. The neglected health and economic impact of STDs. In: Eng TR, Butler WT, eds. The Hidden Epidemic. Washington, DC: National Academy Press; 1997:28-67.
12. Magder LS, Harrison HR, Ehret JM, Anderson TS, Judson FN. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol. 1988;128:298-308.
13. Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kathenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA. 1986;255:1730-1734.
14. Marlotte CK, Wiesmeier E, Gelineau KJ. Screening for Chlamydia cervicitis in a sexually active population. Am J Public Health. 1990;80:469-471.
15. Hillis SD, Nakashima A, Marchbanks PA, Addis DG, Davis JP. Risk factors for recurrent Chlamydia traehomatis infection in women. Am J Obstet Gynecol 1994;170:801-806.
16. Mosure DJ, Herman S, Kleinbaum D, Halloran ME. Predictors of Chlamydia traehomatis among female adolescents: a longitudinal analysis. Am J Epidemiol. 1996;144:997-1003.
17. Oh MK, Cloud GA, Fleenor M, Sturdevant MS, Nesmith JD, Feinstein R A. Risk for gonococeal and chlamydial cervicitis in adolescent females. J Adolese Health. 1996;18:270-275.
18. Westrom L, Mårdh PA. Acute pelvic inflammatory disease. In: Holmes KK, Mardh PA, Sparling PF, et al, eds. Sexually Transmitted Diseases. 2nd ed. New York, NY: McGraw-Hill Book Co; 1990.593-613.
19. American Academy of Pediatrics. Committee on Practice and Ambulatory Medicine. Pediatrics. 1995;96:373-374.
20. Elster A, Kuznets N. AMA Guidelines for Adolescent Preventive Services (GAPS): Recommendations and Rationale. Baltimore, Md: Williams & Wilkins; 1994.
21. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
22. Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Screening women for Chlamydia trackomatis in family planning clinics. Sex Transm Dis. 1998;25: 108-117.
23. Courtney J, Ellen J, Bolan G. Meta-analysis of the sensitivity and specificity of Chlamydia diagnostic tests in females. Presented at: the 12th meeting of the International Society of Sexually Transmitted Diseases Research; October 22, 1997; Seville, Spain. Abstract 0263.
24. Quinn TC, Welsh L, Lentz A, et al. Diagnosis by Amplicor PCR of Chlamydia traehomatis infection in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol. 1996;34:1401-1406.
25. Hook EW, Smith K, Mullen C, et al. Diagnosis of genitourinary Chlamydia traehomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol. 1997;35:2133-2135.
26. Oh MK, Richey CM, Pate CM, Brown PR, Hook EW. High prevalence of Chlamydia traehomatis infections in adolescent females not having pelvic examinations. J Adoleac Health. 1997;21:80-86.
27. Nathanson PG, Fine D, Braxton JR. Program implications of screening for chlamydia beyond family planning and STD clinics. Presented at: the 12th meeting of the International Society of Sexually Transmitted Diseases Research; October 22, 1997;Seville, Spain. Abstract 0248.
28. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs. Sex Transm Dis. 1995;22:15-21.
29. Selvin S. Statistical Analysis of Epidemiologic Data: Monographs in Epidemiology and Biostatistics. Vol 17. New York, NY: Oxford University Press Inc; 1991:285.
30. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrics. 1986;73:13-22.
31. Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia. trachomatis with ligase chain reaction assay. Ann Intern Med. 1997;127:796-803.
32. Borenstein PE, Harvilchuck JD, Rosenthal BH, Santelli JS. Patterns of ICD-9 diagnoses amongadolescents using school-based clinic. J Adolesc Health. 1996;18:203-210.
33. Gans GE.McManus MA, Newacheck PW. Adolescent health care. In: AMA Profiles of Adolescent Health. Chicago, 111: American Medical Association; 1991. No. 6.
34. Lieu TA, Newacheck PW, McManus MA. Race, ethnicity, and access to ambulatory care among US adolescents. Am J Public Health. 1993;83:960-965.
35. Beach RK. Female genitalia. In: Friedman SB, Fisher M, Schonberg SK, eds. Comprehensive Adolescent Health Care. St Louis, Mo: Quality Medical Publishing Inc; 1992:956-989.
36. Neinstein LS, ed. The office visit, interview techniques, and recommendations to parents. In: Adolescent Health Care: A Practical Guide. 3rd ed. Baltimore, Md: Williams & Wilkins; 1996:46-60.
37. Mosure DJ, Herman S, Fine D, DeLisle S, Cates W Jr, Boring JR. Genital chlamydia infections in sexually active female adolescents: do we really need to screen everyone? J Adolesc Health. 1997;20:6-13.
38. Katz BP, Blythe MJ, van der Pol B, et al. Declining prevalences of chlamydia infection among adolescent girls. Sex Transm Dis. 1996;23:226-229.
39. Centers for Disease Control and Prevention. Chlamydia screening practices of primary care providers-Wake County, North Carolina, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:819-822.
40. Gunn R, Veinbergs E, Friedman LS. Adolescent health care providers. Sex Transm Dis. 1997; 24:90-93.
41. Thrall J, McCloskey L, Spivak H, Ettner SL, Tighe JE, Emans SJ. Performance of Massachusetts HMOs in providing Pap smear and sexually transmitted disease screening to adolescent females. J Adolesc Health. 1998;22:184-189.
42. Orr D. Urine based diagnosis of sexually transmitted infections using amplified DNA techniques: a shift in paradigms? J Adolesc Health. 1997;20:3-5.
43. Division of Sexually Transmitted Disease Prevention. Sexually Transmitted Disease Surveillance, 1996. Atlanta, Ga: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; 1997.
44. Hook EW, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Mårdh PA, Sparling PF, et al, eds. Sexually Transmitted Diseases. 2nd ed. New York, NY: McGraw-Hill Book Co; 1990:149-165.
45. Rein MF, Muller M. Trichomonas mginalis and trichomoniasis. In: Holmes KK, Mårdh PA, Sparling PF, et al, eds. Sexually Transmitted Diseases. 2nd ed. New York, NY: McGraw-Hill Book Co; 1990:481-492.
46. Paisarntantiwong R, Brockmann S, Clarke L, Landesman S, Feldman J, Minkoff H. The relationship of vaginal trichomoniasis and pelvic inflammatory disease among women colonized with Chlamydia trachomatis. Sex Transm Dis. 1995;23:344-347.
47. Blythe MJ, Katz BP, Orr DP, Caine VA, Jones RB. Historical and clinical factors associated with Chlamydia trachomatis genitourinary infection in female adolescents. J Pediatr. 1988;112:1000-1004.
48. Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol. 1993;138:143-153.
49. Fisher M, Swenson PD, Risucci D, Kaplan MH. Chlamydia trachomatis in suburban adolescents. J Pediatr. 1987;111:617-620.
50. Winter L, Goldy S, Baer C. Prevalence and epidemiologic correlates of Chlamydia trachomatis in rural and urban populations. Sex Transm Dis. 1990; 1750-36.
51. Cohen D, Nsuami M, Etame RB, et al. A schoolbased chlamydia control program using DNA amplification technology. Pediatrics [serial online]. 1998;101:e1.
52. Thorpe EM, Stamm WE, Hook EW, et al. Chlamydial cervicitis and urethritis. Genitourin Med. 1996:72:93-97.
53. Hillis SD, Coles FB, Litchfield B, et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. Sex Transm Dis. 1998;25:5-11.
54. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinic. Ann Intern Med. 1998;128:277-284.
55. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Sex Transm Dis. 1997;24:131-41.
56. Genç M, Mårdh PA. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med. 1996;124:1-7.